Skip to main content

Day: December 5, 2022

New Study Shows the Majority of Publishers Are Using Commerce Content (87%) and 81% Are Seeing More Return on Investments Outside of Amazon

Digiday and Taboola Survey Shows Publishers Grew Affiliate Marketing As a Significant Revenue Source, As Native Advertising and Affiliate Marketing Make Up the Majority of Revenue NEW YORK, Dec. 05, 2022 (GLOBE NEWSWIRE) — Taboola (Nasdaq: TBLA), a global leader in powering recommendations for the open web, helping people discover things they may like, today announced the results of an independent survey with Digiday, a digital media company exploring technology’s disruption within the global media and marketing industries. Industry forecasts predict the affiliate marketing industry could reach $15.7 billion by 2024 and indicate that searches for “affiliate marketing” increased by nearly 30% throughout 2021. The survey measured how publishers approached affiliate marketing pre-pandemic (in 2019) and how their tactics shifted to...

Continue reading

Concord Acquisition Corp Will Redeem Its Public Shares and Will Not Consummate an Initial Business Combination

New York, New York, Dec. 05, 2022 (GLOBE NEWSWIRE) — Concord Acquisition Corp (NYSE: CND) (the “Company”) today announced that it will redeem all of its outstanding shares of Class A common stock (the “public shares”), effective as of the close of business on December 20, 2022 (the “Redemption Date”), because the Company will not complete an initial business combination within the time period required by its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”). Pursuant to the Company’s Certificate of Incorporation, if the Company has not completed an initial business combination by December 10, 2022, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter subject to lawfully available...

Continue reading

Harbor Custom Development, Inc. Now Leasing Belfair View Apartments

TACOMA, Wash., Dec. 05, 2022 (GLOBE NEWSWIRE) — Harbor Custom Development, Inc. (Nasdaq: HCDI, HCDIP, HCDIW, HCDIZ) (“Harbor,” “Harbor Custom Homes®,” or the “Company”), an innovative and market leading real estate company involved in all aspects of the land development cycle, today announced it is now leasing apartments in Belfair, Washington. The Belfair View Apartments are comprised of 11 three-story buildings featuring one- and two-bedroom rentals approximately 20 minutes from downtown Bremerton conveniences, including the Seattle – Bremerton Ferry Terminal, Bremerton Naval Base, Puget Sound Naval Shipyard and approximately 10 minutes from the Amazon delivery warehouse in Bremerton. The 228-unit complex includes a carport and non-covered onsite parking, a recreational building, outdoor...

Continue reading

NYMOX Announces New Marketing Submission for NYMOZARFEX™ for BPH

IRVINE, Calif., Dec. 05, 2022 (GLOBE NEWSWIRE) — Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to announce today that a new formal submission has been made by the Company in Europe for Fexapotide Triflutate for the treatment of benign prostatic hyperplasia (BPH). The trademarked name for the product in the application is NYMOZARFEX (TM). The Marketing Authorization Application (MAA) was submitted to the Danish authorities. The Company will provide further information, including other expected submissions, when the information becomes available. Paul Averback MD, CEO of Nymox said, “We are extremely pleased to make this announcement today. We thank our team members and many very important collaborators for their efforts and perseverance involved in the ongoing process. This product is a major innovation...

Continue reading

Schouw & Co. share buy-back programme, week 48 2022

On 27 December 2021, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 10 of 21 December 2021. Under the programme, Schouw & Co. will acquire shares for up to DKK 350 million during the period 27 December 2021 to 30 December 2022. The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).Trading day No. of shares Average price Amount    Accumulated until 25/11/2022 503,042 531.08 267,154,455    Monday, 28 November 2022 1,336 514.97 688,000    Tuesday, 29 November 2022 2,152 513.34 1,104,708    Wednesday, 30 November 2022 3,086 513.31 ...

Continue reading

G Medical Innovations to announce receiving of 2 (two) granted patents from the USPTO for its Prizma care and other physiological sensors developed by the company.

Irvine, California, Dec. 05, 2022 (GLOBE NEWSWIRE) — G Medical Innovations Holdings Ltd. (NASDAQ: GMVD) (the “Company” or “G Medical Innovations”) today announced that it received 2 (Two) granted patents from the United States Patent and Trademark office for its monitoring products marketed in the U.S. market. The granted patents are:METHOD, DEVICE AND SYSTEM FOR NON-INVESIVELY MONITORING PHYSIOLOGICAL PARAMETERSThis patent integrates sensing mechanism that allows the monitoring system to analyze the sensing condition (pressure, ambient temperature, light, conductivity, etc.) prior to performing and during continuous monitoring of physiological signals from the body. This allows higher and more accurate sensing that results in reducing false positive reading including false alarms.JACKET FOR MEDICAL MODULEThe patent harness...

Continue reading

Kiboko Gold Provides Update on Harricana Drill Program

ROUYN-NORANDA, Quebec, Dec. 05, 2022 (GLOBE NEWSWIRE) — GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz, LS Exchange, TTMzero, Düsseldorf and Quotrix Düsseldorf Stock Exchanges and GLBXF – OTCQX International in the US) is pleased to update shareholders as regards the work undertaken by Kiboko Gold Inc. (KIB-TSXV) on the Fontana area of the Harricana Gold Project, in Duverny township, Quebec (NTS 32C12). Globex retains a 2% Net Smelter Royalty on Harricana Gold Project claims, including the areas currently being drilled at Fontana and most of the other areas with known significant gold mineralization. Kiboko recently reported that it has completed the initial portion of their Phase 1 exploration program consisting of 55 holes totaling more...

Continue reading

Worthington Industries to Webcast Discussion of Second Quarter 2023 Results on December 21

COLUMBUS, Ohio, Dec. 05, 2022 (GLOBE NEWSWIRE) — Worthington Industries, Inc. (NYSE:WOR) plans to release its second quarter results after the market closes on Tuesday, Dec. 20, 2022. The Company will webcast a live discussion of these results on Wednesday, Dec. 21 at 8:30 a.m. ET. The webcast will be available at www.WorthingtonIndustries.com and will be archived for one year. About Worthington IndustriesWorthington Industries (NYSE:WOR) is a leading industrial manufacturing company pursuing its vision to be the transformative partner to its customers, a positive force for its communities and earn exceptional returns for its shareholders. For over six decades, the Company has been delivering innovative solutions to customers spanning industries such as automotive, energy, retail and construction. Worthington is North America’s...

Continue reading

First Patient Enrolled in Merit Medical’s Multicenter Observational Study to Evaluate the Use of EmboCube® Embolization Gelatin to Control Bleeding or Hemorrhage

SOUTH JORDAN, Utah, Dec. 05, 2022 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today the successful enrollment of the first patient in its prospective, observational study of EmboCube Embolization Gelatin used to control bleeding or hemorrhage. Uncontrolled bleeding, particularly as a result of trauma, is a leading cause of preventable death.1 Globally, roughly 40% of trauma-related deaths result from bleeding.2 Embolization is a minimally-invasive alternative to surgery that can help stop bleeding. The procedure entails the injection of particles (embolic agents) into blood vessels to stop blood flow temporarily or permanently. The choice of embolic agent depends on a variety of factors such as the size of a patient’s blood vessel...

Continue reading

Maris-Tech’s Flagship Product to be Displayed at CES 2023

The Jupiter-AI, multiple-stream video platform with edge artificial intelligence acceleration, will be showcased in the Hailo Hospitality Suite # 27121 at the The Westgate Hotel, Las Vegas North Tower, January 5-8, 2023 REHOVOT, Israel, Dec. 05, 2022 (GLOBE NEWSWIRE) — Maris-Tech Ltd. (Nasdaq: MTEK) (“Maris-Tech” or the “Company”), a B2B provider of intelligent video transmission technology, announced today that its flagship product, the Jupiter-AI, a high-end multiple-stream video platform with edge artificial intelligence acceleration, will be showcased in the Hailo suite at the upcoming CES 2023, the Consumer Electronics Show in Las Vegas, the world’s leading tech annual event. The demonstration will take place at the Westgate Hotel Las Vegas North Tower, Hospitality Suite # 27121, January 5-8, 2023. To schedule...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.